January 27, 2024
5,349
180
58
4.45%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
12:03Now PlayingDr. Melanie Jay, associate professor at NYU Grossman School of Medicine, weighs in on the growing popularity of Type 2 diabetes medication semaglutide, more commonly known as Ozempic, Mounjaro and Wegovy, and the craze surrounding people using it as a treatment for weight loss.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.